Are you Dr. Arora?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2279 45th St
Sacramento, CA 95817Phone+1 916-734-5959Fax+1 916-703-5265
Summary
- Dr. Mili Arora, MD is an oncologist in Sacramento, California. She is currently licensed to practice medicine in California and Massachusetts. She is affiliated with UC Davis Medical Center and is a Clinical Associate at Tufts Medical Center.
Education & Training
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2012 - 2015
Tufts Medical CenterResidency, Internal Medicine, 2009 - 2012
George Washington University School of Medicine and Health SciencesClass of 2009
Certifications & Licensure
CA State Medical License 2012 - 2025
MA State Medical License 2009 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01 - 6 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01 - 12 citationsA randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt
NPJ Breast Cancer. 2022-12-30
Press Mentions
Can Turmeric Reduce Joint Pain During Breast Cancer Treatment?July 14th, 2021
